More on pneumonia: Treatment of MRSA in community acquired pneumonia

BMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7553.1334 (Published 01 June 2006) Cite this as: BMJ 2006;332:1334
  1. James Greig (James.Greig@PHNT.swest.nhs.uk), consultant microbiologist,
  2. Peter Jenks, consultant microbiologist
  1. Department of Microbiology, Derriford Hospital, Plymouth PL6 8DH
  2. Department of Microbiology, Derriford Hospital, Plymouth PL6 8DH

    EDITOR—Hoare and Lim's update on the diagnosis and management of community acquired pneumonia does not mention methicillin resistant Staphylococcus aureus (MRSA),1 which is becoming more common in the community as a true community associated organism, in patients in residential care, and in those discharged from hospital. Patients who have newly acquired MRSA often develop further infections unless carriage is cleared. One study showed that in the 18 months after first colonisation, over one quarter of individuals developed further MRSA infections, many of which were …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial